Diagnostic value of serum HER2 levels in breast cancer: a systematic review and meta-analysis

Diagnostic value of serum HER2 levels in breast cancer: a systematic review and meta-analysis

10.1186/s12885-020-07545-2

Saved in:

Bibliographic Details
Main Authors:	Shamshirian, A., Aref, A.R., Yip, George W., Ebrahimi Warkiani, M., Heydari, K., Razavi Bazaz, S., Hamzehgardeshi, Z., Shamshirian, D., Moosazadeh, M., Alizadeh-Navaei, R.
Other Authors:	ANATOMY
Format:	Article
Published:	BioMed Central Ltd 2021
Subjects:	Breast neoplasm erbB2 Immunoassay Serum HER-2
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/199522
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Mucinous cystadenocarcinoma of the breast with amplification of the HER2-gene confirmed by FISH: The first case reported
by: Petersson, F., et al.
Published: (2012)

Over-expression of c-erbB-2 correlates with nuclear morphometry and prognosis in breast carcinoma in Asian women
by: Selvarajan, S., et al.
Published: (2011)

Over-expression of c-erbB-2 correlates with nuclear morphometry and prognosis in breast carcinoma in Asian women
by: Selvarajan, S., et al.
Published: (2012)

In vitro and in vivo antitumor effect of a trivalent bispecific antibody targeting ErbB2 and CD16
by: Lu, H., et al.
Published: (2011)

Construction and functional identification of a novel trivalent anti-ErbB2/anti-CD16 bispecific antibody
by: Lu, H., et al.
Published: (2011)

THE ROLE OF AUTOCRINE HUMAN GROWTH HORMONE (HGH) IN HER2+ BREAST CARCINOMA CELLS
by: LAU YONG CHEN AMY
Published: (2015)

C-erBB2 over-expression in invasive breast carcinoma
by: SATHIYAMOORTHY SELVARAJAN
Published: (2010)

Preclinical characteristics of the irreversible pan- her kinase inhibitor neratinib compared with lapatinib: Implications for the treatment of HER2- positive and HER2-mutated breast cancer
by: Collins, D.M., et al.
Published: (2021)

Proteomic characterization of differentially expressed proteins in breast cancer: Expression of hnRNP H1, RKIP and GRP78 is strongly associated with HER-2/neu status
by: Zhang, D., et al.
Published: (2012)

Proteomics analysis of Her-2/neu-linked protein profiles in tumor microenvironment
by: TAI LEE KIAN
Published: (2010)

Brain metastases in Asian HER2-positive breast cancer patients: Anti-HER2 treatments and their impact on survival
by: Yap, Y.S., et al.
Published: (2014)

Overexpression of CC3/TIP30 is associated with HER-2/neu status in breast cancer
by: Zhang, D.-H., et al.
Published: (2012)

The study of interactions of transmembrane receptors and intracellular signaling proteins in live cells by fluorescence correlation and cross-correlation spectroscopy
by: LIU PING
Published: (2011)

EZH2-MEDIATED REPRESSION OF PPP2R2B PROMOTES RESISTANCE TO ANTI-HER2 TREATMENT IN BREAST CANCER
by: BAO YI
Published: (2020)

Detection of HER2/neu gene amplification in archival paraffin-embedded breast cancer tissues by fluorescence in situ hybridization
by: Selvarajan, S., et al.
Published: (2015)

THE ROLE OF TREFOIL FACTOR 3 IN MEDIATING RESISTANCE TOWARDS HER2-TARGETED DRUGS IN BREAST CANCER
by: CHONG QING YUN
Published: (2017)

The breast cancer working group presentation was divided into three sections: The epidemiology, pathology and treatment of breast cancer
by: Toi, M., et al.
Published: (2014)

D-amino acid peptide residualizing agents for protein radioiodination: Effect of aspartate for glutamate substitution
by: Pruszynski, M., et al.
Published: (2022)

Tyrosine phosphorylation of PP2A is regulated by HER-2 signalling and correlates with breast cancer progression
by: Wong, L.L., et al.
Published: (2012)

Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
by: Lim, JSJ, et al.
Published: (2023)

Potential therapeutic significance of HER-family in esophageal squamous cell carcinoma
by: Kono, K., et al.
Published: (2014)

Heregulin-Enhanced Tyrosine Phosphorylation in Breast Cancer Cells: Role of PP2A in HER-2/neu Oncogenic Signalling
by: WONG LEE LEE
Published: (2011)

Silencing of the PP2A catalytic subunit causes HER-2/neu positive breast cancer cells to undergo apoptosis
by: Wong, L.L., et al.
Published: (2012)

Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-γ-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector
by: Huang, H., et al.
Published: (2014)

Evaluation of the relative effectiveness of the 2017 updated Manchester scoring system for predicting BRCA1/2 mutations in a Southeast Asian country
by: Chew, Winston, et al.
Published: (2019)

ELUCIDATING THE ROLE OF WBP2 IN INSULIN AND AMPK SIGNALING- IMPLICATIONS IN METFORMIN ANTI-CANCER EFFECT IN BREAST CANCER
by: LIN HEXIAN
Published: (2023)

HER-2-mediated endocytosis of magnetic nanospheres and the implications in cell targeting and particle magnetization
by: Wuang, S.C., et al.
Published: (2014)

Engineer her future: a communication campaign to encourage parents to expose their primary and lower secondary school daughters to engineering through a collaborative and interactive journey
by: Priyadarshini, A, et al.
Published: (2024)

Trastuzumab decorated nanoparticles for targeted chemotherapy of breast cancer
by: Sun, B., et al.
Published: (2014)

Trastuzumab decorated nanoparticles for targeted chemotherapy of breast cancer
by: Sun, B., et al.
Published: (2014)

Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer
by: Yadav, Kritika, et al.
Published: (2023)

On Dr. Foronda's Mother Ignacia and her beaterio
by: Perfecto, Waldo S.
Published: (1963)

Fluorescence-based immunosensor using three-dimensional CNT network structure for sensitive and reproducible detection of oral squamous cell carcinoma biomarker
by: Song, Chung Kil, et al.
Published: (2020)

Multifunctional poly(d,l-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer
by: Sun, B., et al.
Published: (2014)

Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells
by: Chua, A.W.L., et al.
Published: (2014)

Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma
by: Chong, Q.-Y, et al.
Published: (2020)

The ERBB2 Exonic Variant Pro1170Ala Modulates Mitogen-Activated Protein Kinase Signaling Cascades and Associates with Allergic Asthma
by: Sio, Yang Yie, et al.
Published: (2023)

A graphene oxide and copper-centered metal organic framework composite as a tri-functional catalyst for HER, OER, and ORR
by: Jahan, M., et al.
Published: (2014)

Snai1-driven sequential emt changes attributed by selective chromatin enrichment of RAD21 and GRHL2
by: Sundararajan, V., et al.
Published: (2021)

3D-PRINTED NI-BASED ELECTRODES FOR HIGH-CURRENT DENSITY WATER-SPLITTING APPLICATION (HER AND OER)
by: ZHANG KAIXI
Published: (2024)